Recombinant Human MIP-3 alpha (CCL20)|重組人MIP-3|純度> 97 %|現貨|產品詳情

聯系電話：400 608 7598
客戶專員：劉小姐

產品名稱：Recombinant Human MIP-3 alpha (CCL20)|重組人MIP-3|純度> 97 %|現貨|產品詳情

Catalog Number: C22- 204-20
Source: Escherichia coli.
Molecular Weight: Approximately 8.0 kDa, a single non-glycosylated polypeptide chain containing 70 amino acids.
Quantity: 5µg/20µg/1000µg
AA Sequence: ASNFDCCLGY TDRILHPKFI VGFTRQLANE GCDINAIIFH TKKKLSVCAN PKQTWVKYIV
RLLSKKVKNM
Purity: > 97 % by SDS-PAGE and HPLC analyses.
Biological Activity: Fully biologically active when compared to standard. The biological activity determined by a
chemotaxis bioassay using human T-lymphocytes is in a concentration range of 10-50 ng/ml.
Physical Appearance: Sterile Filtered White lyophilized (freeze-dried) powder.
Formulation: Lyophilized from a 0.2 ?m filtered concentrated solution in 20 mM PB, pH 7.4, 100 mM NaCl.
Endotoxin: Less than 1 EU/?g of rHuMIP-3α/CCL20 as determined by LAL method.
Reconstitution: We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the
bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a
concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and
stored at ≤ -20 ?C. Further dilutions should be made in appropriate buffered solutions.
Storage: This lyophilized preparation is stable at 2-8 ?C, but should be kept at -20 ?C for long term storage,
preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 ?C. For
maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 ?C to
-70 ?C. Avoid repeated freeze/thaw cycles.

查詢關鍵詞：Recombinant Human MIP-3 alpha (CCL20)，重組人MIP-，純度> 97 %，現貨，產品詳情，原料藥，大包裝定制，現貨促銷，醫藥中間體，科學儀器，實驗室耗材，生化試劑，創賽中國

CANSPEC品質提供的Recombinant Human MIP-3 alpha (CCL20)|重組人MIP-3|純度> 97 %|現貨|產品詳情性能**，其優良的品質滿足您不同實驗的多種需求。
本產品由上海創賽品質提供，歡迎咨詢國內免費服務專線：400-608-7598，更多產品信息請登錄www.getprovidencehotels.com或www.4006087598.com

其他細胞因子產品：

IL-1α，IL-1β，IL-1RA，IL-2，IL-3，IL-4，IL-6，IL-8(77a.a.)，IL-10，IL-11，IL-12，IL-13，IL-15，IL-17，SCF，G-CSF，GM-CSF，EPOα，TPO，TSLP，PEDF，TNF-α，TNF-β，Enbrel，BLyS，Flt3-L，SCD40-L，LIF，OSM，aFGF，bFGF，KGF1，KGF2，EGF，VEGF165，EPG，IFN-α1a，IFN-α1b，IFN-α2a，IFN-α2b，IFN-β1b，IFN-γ，GMF-β，CNTF，BNP，NRG-1，BMP-2，BMP-7，OPG-Fc，Noggin，BD-1 (47a.a.)，BD-2，BD-3，BD-4